No Data
No Data
Blueprint Medicines Corporation (NASDAQ:BPMC) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Blueprint Medicines Corporation Just Reported A Surprise Profit And Analysts Updated Their Estimates
Blueprint Medicines First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
A Quick Look at Today's Ratings for Blueprint Medicines(BPMC.US), With a Forecast Between $125 to $150
A Quick Look at Today's Ratings for Blueprint Medicines(BPMC.US), With a Forecast Between $102 to $130
Analysts Conflicted on These Healthcare Names: Blueprint Medicines (BPMC), Envista Holdings (NVST) and Hologic (HOLX)